| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 14 buys and 20 sells.
Estimated insider holdings value: $2043.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 362,240 | $15.00 | $5,433,371.60 | +5.7% | |
| Jan 30, 2018 | ACET Adicet Bio, Inc. | Director, 10% Owner | Buy | 533,333 | $15.00 | $7,999,995.00 | +12.4% | |
| Jan 29, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 72,760 | $14.97 | $1,089,306.80 | +1.2% | |
| Jan 24, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 257,285 | $14.88 | $3,828,990.49 | +1.8% | |
| Jan 12, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 240,484 | $13.28 | $3,192,709.94 | +3.1% | |
| Jan 3, 2018 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Sell | 1,709,620 | $7.35 | $12,565,707.00 | -23.5% | |
| Dec 18, 2017 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Sale+OE | 147,635 | $5.70 | $841,519.50 | -2.0% | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner | Buy | 355,000 | $17.00 | $6,035,000.00 | +13.9% | |
| Sep 5, 2017 | GKOS Glaukos Corp | Director | Sell | 580,200 | $38.73 | $22,472,822.20 | -9.6% | |
| Aug 17, 2017 | GKOS Glaukos Corp | Director | Sell | 325,000 | $37.93 | $12,326,042.80 | -6.4% |